Uterine Artery Embolization for Pedunculated Subserosal Leiomyomas: Evidence of Safety and Efficacy
Other
OA: green
CC0
⤵ 4 in-corpus citations
AI-generated summary
This paper provides evidence for the safety and efficacy of uterine artery embolization as a treatment for pedunculated subserosal leiomyomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PURPOSE: To evaluate safety and efficacy of uterine artery embolization (UAE) for pedunculated subserosal (PS) leiomyomas.
MATERIALS AND METHODS: Of 1,069 patients who underwent UAE for symptomatic leiomyomas or adenomyosis from 2007 to 2016, 55 patients (mean age 40.3 y ± 4.8) with 66 PS leiomyomas (mean diameter 6.61 cm ± 2.04) were enrolled. Each PS leiomyoma was categorized into 1 of 2 groups: high-risk PS leiomyoma (stalk diameter < 25% of diameter of leiomyoma) and low-risk PS leiomyoma (stalk diameter 25%-50% of diameter of leiomyoma). MR imaging was performed 3 months after UAE. Rates of infarction and volume reduction were compared between PS leiomyomas and non-PS dominant leiomyomas and between high-risk and low-risk PS leiomyomas. Complications related to PS leiomyomas were assessed.
RESULTS: At a median follow-up of 96 days (range, 36-348 d) after UAE, none of the patients (0%) had complications related to PS leiomyomas, even among high-risk cases. Mean volume reductions of 38.2% and 38.4% were achieved for PS leiomyomas and non-PS dominant leiomyomas, respectively (P = .953). There were 3 (5.5%) minor adverse events, but none were related to PS leiomyoma. There was no significant difference in volume reduction and infarction rates between low-risk and high-risk PS leiomyomas.
CONCLUSIONS: UAE is safe and effective in patients with PS leiomyomas even for high-risk cases (stalk diameter < 25% of diameter of leiomyoma). PS leiomyoma should not be considered a contraindication for UAE.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Treatment of adenomyosis, abdominal wall endometriosis and uterine leiomyoma with interventional radiology: A review of current evidences 2023
- Interventional Radiology in Obstetrics and Gynecology: Updates in Women's Health 2023
- Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases 2019
- Uterine Fibroids and Adenomyosis: Imaging and Treatment 2021
References (14)
- W1976736334 via openalex
- W2011970483 via openalex
- W2016359081 via openalex
- W2021151640 via openalex
- W2025941379 via openalex
- W2103162783 via openalex
- W2112920670 via openalex
- W2124126126 via openalex
- W2128020863 via openalex
- W2146646184 via openalex
- W2147763751 via openalex
- W4249178477 via openalex
- W4285719527 via openalex
- W6725714224 via openalex
Cited by (4)
- Interventional Radiology in Obstetrics and Gynecology: Updates in Women's Health 2023
- Treatment of adenomyosis, abdominal wall endometriosis and uterine leiomyoma with interventional radiology: A review of current evidences 2023
- Uterine Fibroids and Adenomyosis: Imaging and Treatment 2021
- Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases 2019
Source provenance
- europepmc
- last seen: 2026-11-18T06:10:28.346261+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:21:33.560900+00:00
License: CC0
· commercial use OK